DNA topoisomerase I and II in cancer chemotherapy: update and perspectives
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 32 (2) , 103-108
- https://doi.org/10.1007/bf00685611
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugsJournal of Molecular Biology, 1991
- Mode of action of the new quinolones: New dataEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.The Journal of cell biology, 1990
- Teniposide, a topoisomerase II inhibitor, prevents chromosome condensation and separation but not decondensation in fertilized surf clam (Spisula solidissima) oocytesDevelopmental Biology, 1990
- Acidic phospholipids directly inhibit DNA binding of mammalian DNA topoisomerase IFEBS Letters, 1990
- Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideEuropean Journal of Cancer and Clinical Oncology, 1990
- Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiaeJournal of Molecular Biology, 1989
- Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase IIBiochemistry, 1986
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966